SCHEMBL26871688

SCHEMBL26871688

c1nn2c(NC3CCCC3)cc(C(C3CC3)C3CC3)nc2c1C1CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CSNK2B P67870 1/20 0.46
▸ RAB9A P51151 3/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ NPC1 O15118 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ NR2F2 P24468 1/20 0.41
▸ CCNT1 O60563 6/20 0.41
▸ CDK9 P50750 6/20 0.41
▸ CDK2 P24941 4/20 0.40
▸ GSK3B P49841 1/20 0.40
▸ CDK4 P11802 3/20 0.39
▸ CCND1 P24385 3/20 0.39
▸ CDK7 P50613 3/20 0.39
▸ CCNH P51946 3/20 0.39
▸ CDK1 P06493 2/20 0.39
▸ CCNA2 P20248 2/20 0.39
▸ CCNE1 P24864 2/20 0.39
▸ CCNA1 P78396 2/20 0.39
▸ CDK3 Q00526 2/20 0.39
▸ CDK6 Q00534 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL33377999 0.66 CSNK2B (0.60) CSNK2BRAB9AMEN1NPC1KMT2A
SCHEMBL24174228 0.64 CDK2 (0.50) CSNK2BRAB9AMEN1NPC1KMT2A
SCHEMBL11931171 0.63 MAP3K5 (0.45) CSNK2BCDK2GSK3BCCNA2
SCHEMBL1934608 0.62 CSNK2B (1.00) CSNK2BRAB9AMEN1NPC1KMT2A
SCHEMBL22899497 0.62 CDK2 (0.46) CSNK2BRAB9AMEN1NPC1KMT2A
SCHEMBL22899498 0.62 RAB9A (0.51) CSNK2BRAB9AMEN1NPC1KMT2A
SCHEMBL21877782 0.61 CCNT1 (0.95) CCNT1CDK9CDK2CDK4CCND1
SCHEMBL24174230 0.61 CDK9 (0.62) CCNT1CDK9CDK2CDK4CCND1
SCHEMBL30083614 0.60 KDR (0.38) CSNK2BCDK2GSK3BKCNH2
SCHEMBL21877697 0.60 CCNT1 (0.93) CCNT1CDK9CDK2CDK4CCND1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4282868-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIMIDINE-7-AMINE DERIVATIVE, AND COMPOSITIONS AND MEDICAL USE THEREOF Shanghai Haiyan Pharmaceutical Technology Co., Ltd (CN) 2023-11-29 — — EP disclosed
Send feedback